Dry Needling in Multiple Sclerosis
What it found
No result yet.
What was tested
Treatment tested
- Dry Needling
Placebo or sham
- Sham Dry Needling
What it measured
Main measures
Percentage of Planned Dry Needling Treatment Sessions Completed
immediately after the intervention
Quality of life (reported by participants)FeasibilityPercentage of Dry Needling Sites With an Elicited Local Twitch Response
immediately after the intervention
Treatment Credibility Score on the Credibility/Expectancy Questionnaire
immediately after the intervention
Number of Serious Adverse Events During Study Participation
immediately after the intervention
SafetyFeasibility
Other measures (5)
The Patient-Reported Outcomes Measurement Information System Pain Intensity
Baseline, 3 weeks (post-treatment), and 1 month after treatment completion
PainQuality of life (reported by participants)Change in Pressure Pain Threshold Measured Using a Pressure Algometer
Baseline, 3 weeks (post-treatment), and 1 month after treatment completion.
PainChange in Walking Performance Measured by the Timed 25-Foot Walk Test
Baseline, 3 weeks (post-treatment), and 1 month after treatment completion.
Disability progressionWalking and mobilityChange in Functional Mobility Measured by the Timed Up and Go Test
Baseline, 3 weeks (post-treatment), and 1 month after treatment completion.
Walking and mobilityChange in Postural Sway Measured by an Accelerometer During Static Standing
Baseline, 3 weeks (post-treatment), and 1 month after treatment completion.
Walking and mobility
Who could take part
MS (type not specified) · 18 to 80
**Inclusion Criteria:** * Diagnosis of Multiple Sclerosis (MS) based on the McDonald criteria * Patient Determined Disease Steps (PDDS) score of 1-5 (ambulatory participants) * Ability to communicate in written and spoken English * Age 18-80 years * Chronic lower-extremity pain lasting more than three consecutive months, with a pain intensity of at least 3 out of 10 on the Numeric Pain Rating Scale (NPRS) **Exclusion Criteria:** * Any neurological comorbidity (e.g., stroke or Parkinson's disease) * MS relapse within the past 30 days * Current participation in or planned initiation of any pain management intervention (interventional or rehabilitative) targeting the lower extremity * Anticipated changes in pain medication during the study period * Pregnancy, as determined by a urine pregnancy test * Active cancer or chemotherapy within the past year * Montreal Cognitive Assessment (MoCA) score below 17 * Known or suspected infection in the lower extremity * Deep vein thrombosis * Thrombophlebitis * Active osteomyelitis in the lower extremity * Varicose veins * Uncontrolled seizures or epilepsy
As registered. Criteria can change, so ask the trial team or your neurologist.
Contact details on the registryAbout this trial
In the sponsor's words
This study is being conducted at the Human Functional Performance Laboratory in the School of Physical Therapy and Rehabilitation Sciences (MDT Building) at the University of South Florida. The study is supported by the Consortium of Multiple Sclerosis Centers. The investigators are conducting this study to determine whether a treatment called dry needling can improve chronic pain in the lower body (from the low back to the foot) in people with Multiple Sclerosis. Dry needling involves inserting tiny needles, similar to those used in acupuncture, into specific muscles, such as the thigh or calf muscles. Unlike traditional acupuncture, dry needling targets specific muscle areas to reduce muscle stiffness and pain. Dry needling may help reduce pain without medication. The investigators also aim to determine whether dry needling can improve balance and walking abilities, potentially leading to better day-to-day functioning. Participants will be assigned to one of two groups. Both groups will receive six treatment sessions. One group will receive actual dry needling, while the other group will receive a sham procedure designed to mimic dry needling. Treatment assignment will be determined randomly, similar to flipping a coin. Neither participants nor the study doctor will choose the assigned treatment. Each participant will have an equal chance of receiving actual dry needling or the sham procedure. Participants will not be informed of the assigned treatment; however, the study doctor will know the treatment assignment. Participants are being invited to take part in this study because of a diagnosis of Multiple Sclerosis and the presence of chronic pain in the lower body, including the buttocks, thighs, calves, or feet. The investigators aim to determine whether dry needling can help reduce chronic lower-body pain in people with Multiple Sclerosis.
Loading reviews and guidelines…
History
Started
May 2026
Main results due
May 2027
Finished
Jun 2027
Assembled by software from public sources and not checked by people. Each record links to its source. Report an error